Vivoryon Therapeutics AG Stock price Euronext Amsterdam
Equities
DE0007921835
Biotechnology & Medical Research
Sales 2023 * | - | Sales 2024 * | - | Capitalization | 14.08M 15.17M |
---|---|---|---|---|---|
Net income 2023 * | -23M -24.79M | Net income 2024 * | -18M -19.4M | EV / Sales 2023 * | - |
Net cash position 2023 * | 24.1M 25.97M | Net cash position 2024 * | 19.55M 21.07M | EV / Sales 2024 * | - |
P/E ratio 2023 * |
-0.58
x | P/E ratio 2024 * |
-0.75
x | Employees | - |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 66.82% |
Latest transcript on Vivoryon Therapeutics AG
Managers | Title | Age | Since |
---|---|---|---|
Frank Weber
CEO | Chief Executive Officer | 64 | 11-12-31 |
Anne Doering
DFI | Director of Finance/CFO | - | - |
Director/Board Member | 56 | 18-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 74 | 06-12-31 | |
Director/Board Member | 54 | 06-12-31 | |
Anne Doering
DFI | Director of Finance/CFO | - | - |
1st Jan change | Capi. | |
---|---|---|
+9.30% | 46.03B | |
+52.73% | 44.55B | |
+7.15% | 40.8B | |
-8.78% | 28.25B | |
+18.68% | 27.71B | |
-21.92% | 18.82B | |
+14.62% | 13.91B | |
+31.85% | 12.43B | |
+4.47% | 10.81B |